http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111093765-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5fada5ba915dca7e413ccad0f57febb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2021-0044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0626
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04L67-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04L67-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04L67-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H05B47-10
filingDate 2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185de098422088f046a4aaddd3e0fa9d
publicationDate 2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111093765-A
titleOfInvention Circadian rhythm coordination using light therapy to enhance drug effectiveness
abstract The circadian synergy platform can use a drug circadian profile that includes the mapping of a drug to a circadian disruption and can convert this circadian disruption into the administration of phototherapy to accommodate this disruption. The circadian rhythm coordination platform can specify how phototherapy can be used to coordinate a patient's circadian rhythm to compensate or anticipate drug side effects, and optimize drug schedules for a patient's circadian rhythm to minimize side effects and increase drug efficacy. The Circadian Synergy Platform can also collect information on the effects of drugs on circadian rhythms and interact with patients, medical providers, and other providers associated with light therapy.
priorityDate 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896

Total number of triples: 36.